MEDICO REMEDIES share price has plunged 10% and is presently trading at Rs 45.6.
Meanwhile, the BSE HEALTHCARE index is at 42,360.7 (up 0.6%).
Among the top losers in the BSE HEALTHCARE index today are Jubilant Pharmova (down 0.4%) and ALKEM LABORATORIES (down 0.2%).
GRANULES INDIA (up 3.9%) and ERIS LIFESCIENCES (up 3.6%) are among the top gainers today.
Over the last one year, MEDICO REMEDIES has moved down from Rs 78.7 to Rs 45.6, registering a loss of Rs 33.1 (down 42.1%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,951.5 to 42,360.7, registering a gain of 46.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 173.2%), SUVEN PHARMACEUTICALS (up 125.8%) and Glenmark Pharma (up 97.3%).
The BSE Sensex is at 78,042.6 (up 0.9%).
The top gainers among the BSE Sensex today are M&M (up 3.2%) and MUNDRA PORT & SEZ (up 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 23,675.7 (up 1.0%). Trent and M&M are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,675.9 to 78,042.6, registering a gain of 12,366.7 points (up 18.8%).
MEDICO REMEDIES net profit fell 35.9% YoY to Rs 16 million for the quarter ended September 2024, compared to a profit of Rs 24 million a year ago. Net sales declined 7.1% to Rs 393 million during the period as against Rs 424 million in July-September 2023.
For the year ended March 2024, MEDICO REMEDIES reported 14.5% increase in net profit to Rs 83 million compared to net profit of Rs 72 million during FY23. Revenue of the company grew 3.2% to Rs 1,449 million during FY24.
The current Price to earnings ratio of MEDICO REMEDIES , based on rolling 12 month earnings, stands at 49.3.
Equitymaster requests your view! Post a comment on "MEDICO REMEDIES Plunges 10%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!